Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Alan Pollack

Showing results (91-100 of 265) with videos related to

Pageof 27
Sort By:
International Journal of Radiation Oncology, Biology, Physics|February 18, 2004
Intensity-modulated radiotherapy with MRI simulation to reduce doses received by erectile tissue during prostate cancer treatmentMark K Buyyounouski, Eric M Horwitz, Robert A Price, et al.
Urology|February 19, 2008
Does transurethral resection of prostate (TURP) affect outcome in patients who subsequently develop prostate cancer?David J D'Ambrosio, Karen Ruth, Eric M Horwitz, et al.
Journal of the National Cancer Institute|April 5, 2017
Prospective Validation of Diagnostic Tumor Biomarkers in Men Treated With Radiotherapy for Prostate CancerAlan Pollack, Deukwoo Kwon, Gail Walker, et al.
International Journal of Radiation Oncology, Biology, Physics|December 14, 2004
In regard to Selek et al. erectile dysfunction and radiation dose to penile base structures: a lack of correlation. IJROBP 2004;59:1039-1046Mark K Buyyounouski, Alexandra L Hanlon, Robert A Price, et al.
The Journal of Urology|February 10, 2004
Prostate cancer radiotherapy dose response: an update of the fox chase experienceAlan Pollack, Alexandra L Hanlon, Eric M Horwitz, et al.
Strahlentherapie Und Onkologie : Organ Der Deutschen Rontgengesellschaft ... [Et Al]|October 21, 2016
Dynamic contrast-enhanced MRI for automatic detection of foci of residual or recurrent disease after prostatectomyN Andres Parra, Amber Orman, Kyle Padgett, et al.
International Journal of Radiation Oncology, Biology, Physics|April 3, 2007
What dose of external-beam radiation is high enough for prostate cancer?Thomas N Eade, Alexandra L Hanlon, Eric M Horwitz, et al.
Molecular Cancer Therapeutics|March 6, 2016
Edelfosine Promotes Apoptosis in Androgen-Deprived Prostate Tumors by Increasing ATF3 and Inhibiting Androgen Receptor ActivityThirupandiyur S Udayakumar, Radka Stoyanova, Mohammed M Shareef, et al.
International Journal of Radiation Oncology, Biology, Physics|August 11, 2007
Prognostic value of abnormal p53 expression in locally advanced prostate cancer treated with androgen deprivation and radiotherapy: a study based on RTOG 9202Mingxin Che, Michelle DeSilvio, Alan Pollack, et al.
International Journal of Radiation Oncology, Biology, Physics|July 5, 2005
Adenoviral-E2F-1 radiosensitizes p53wild-type and p53null human prostate cancer cellsKhanh H Nguyen, Paul Hachem, Li-Yan Khor, et al.
Pageof 27

Showing results (91-100 of 265) with videos related to

Sort By:
Pageof 27
International Journal of Radiation Oncology, Biology, Physics|February 18, 2004
Intensity-modulated radiotherapy with MRI simulation to reduce doses received by erectile tissue during prostate cancer treatmentMark K Buyyounouski, Eric M Horwitz, Robert A Price, et al.
Urology|February 19, 2008
Does transurethral resection of prostate (TURP) affect outcome in patients who subsequently develop prostate cancer?David J D'Ambrosio, Karen Ruth, Eric M Horwitz, et al.
Journal of the National Cancer Institute|April 5, 2017
Prospective Validation of Diagnostic Tumor Biomarkers in Men Treated With Radiotherapy for Prostate CancerAlan Pollack, Deukwoo Kwon, Gail Walker, et al.
International Journal of Radiation Oncology, Biology, Physics|December 14, 2004
In regard to Selek et al. erectile dysfunction and radiation dose to penile base structures: a lack of correlation. IJROBP 2004;59:1039-1046Mark K Buyyounouski, Alexandra L Hanlon, Robert A Price, et al.
The Journal of Urology|February 10, 2004
Prostate cancer radiotherapy dose response: an update of the fox chase experienceAlan Pollack, Alexandra L Hanlon, Eric M Horwitz, et al.
Strahlentherapie Und Onkologie : Organ Der Deutschen Rontgengesellschaft ... [Et Al]|October 21, 2016
Dynamic contrast-enhanced MRI for automatic detection of foci of residual or recurrent disease after prostatectomyN Andres Parra, Amber Orman, Kyle Padgett, et al.
International Journal of Radiation Oncology, Biology, Physics|April 3, 2007
What dose of external-beam radiation is high enough for prostate cancer?Thomas N Eade, Alexandra L Hanlon, Eric M Horwitz, et al.
Molecular Cancer Therapeutics|March 6, 2016
Edelfosine Promotes Apoptosis in Androgen-Deprived Prostate Tumors by Increasing ATF3 and Inhibiting Androgen Receptor ActivityThirupandiyur S Udayakumar, Radka Stoyanova, Mohammed M Shareef, et al.
International Journal of Radiation Oncology, Biology, Physics|August 11, 2007
Prognostic value of abnormal p53 expression in locally advanced prostate cancer treated with androgen deprivation and radiotherapy: a study based on RTOG 9202Mingxin Che, Michelle DeSilvio, Alan Pollack, et al.
International Journal of Radiation Oncology, Biology, Physics|July 5, 2005
Adenoviral-E2F-1 radiosensitizes p53wild-type and p53null human prostate cancer cellsKhanh H Nguyen, Paul Hachem, Li-Yan Khor, et al.
Pageof 27